DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main
BankPosition in AMGN — Amgen Inc
CIK 1694217
FRANKFURT AM MAIN, 2M
Position in AMGN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$65,640,782
+$27,595,252 QoQ
Shares Held
186,559
+60.5% QoQ
Ownership
0.035%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 23.565199213117566.ToString("F0")%
Shared 0.ToString("F0")%
None 76.43480078688243.ToString("F0")%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Derivatives in AMGN
reported options exposure · as of Mar 31, 2024CallValue
$0
CallShares
0
PutValue
$68,919,168
PutShares
242,400
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main holds $6,138,982,939 across 11 Drug Manufacturers - General names. AMGN ranks #8 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
12,938,604 | $2,551,751,478 | |
| 2 | JNJ |
Johnson & Johnson
|
6,172,828 | $1,508,886,072 | |
| 3 | LLY |
ELI LILLY & Co
|
1,263,243 | $1,161,893,009 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
2,122,979 | $295,879,581 | |
| 5 | ABBV |
AbbVie Inc.
|
1,091,285 | $237,343,571 | |
| 6 | MRK |
Merck & Co., Inc.
|
1,705,178 | $205,115,859 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
1,163,953 | $70,593,748 | |
| 8 | AMGN |
Amgen Inc
This page
|
186,559 | $65,640,782 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $65,640,782 | 186,559 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $38,045,530 | 116,237 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $27,991,133 | 99,189 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $26,074,023 | 93,385 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $25,211,558 | 80,923 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $40,439,597 | 155,155 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $116,376,127 | 361,181 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $117,955,495 | 377,518 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $160,123,050 | 563,179 | Shares | Defined | 2024-05-15 | |
| 2024-03-31 | $68,919,168 | 242,400 | Put | Defined | 2024-05-15 | |
| 2023-12-31 | $190,771,772 | 662,356 | Shares | Defined | 2024-02-16 | |
| 2023-09-30 | $136,313,455 | 507,194 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $68,975,616 | 310,673 | Shares | Defined | 2024-05-17 | |
| 2023-03-31 | $71,655,664 | 296,404 | Shares | Sole | 2024-05-17 | |
| 2022-12-31 | $37,555,679 | 142,993 | Shares | Defined | 2024-05-17 | |
| 2022-09-30 | $33,113,512 | 146,910 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $52,753,277 | 216,824 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $85,469,100 | 353,441 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $81,491,105 | 362,231 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $67,164,862 | 315,847 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $60,827,079 | 249,547 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $70,734,441 | 284,291 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $64,582,916 | 280,893 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $59,708,535 | 234,925 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $51,089,868 | 216,611 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $47,934,694 | 236,446 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||